BIOTECH EQUITIES ANALYST

< back to Careers

Type: Full or Part-time
Location: United States, Remote 

Description
Diviner is seeking a full-time (or part-time) Biotech Equities Analyst to apply a strong understanding of both the science and the business of drug development to research clinical-stage drugs our expert network is assessing. 

Ideal Candidate
You have excelled as a therapeutics/biotech analyst on the sell-side, or at an investment firm. You have a passion for therapeutics equities research. You know how to assess company stock valuations via a range of valuation methodologies using multiple information sources. You thrive when collaborating with a small team of peers and senior leaders, partnering with them as you research new opportunities. You enjoy participating in discussions about biotech valuations, seeking valid, data-driven consensus to inform critical company deliverables. 

Essential Responsibilities

  • Analyze valuations of small/mid-cap biotech companies
  • Utilize various valuation methodologies to predict up/down stock movements for upcoming key catalysts (clinical data readouts, regulatory decisions)
  • Review publicly available data to determine the most relevant inputs in valuation including an evaluation of a company’s financial status, pipeline, therapeutic indication(s), and competitive landscape 
  • Collaborate closely with the team to reach “group consensus” on modeling valuation inputs and implied market probabilities for key catalysts
  • Participate in discussions comparing the market-implied probability of success with internal estimates to determine if there is a potential trading opportunity

Experience Required

  • Minimum 4+ years Buyside/Sellside equity research covering therapeutics in small/mid-cap Biotech or Pharma (no traders, no equity sales)
  • Valuation and modeling of biopharma companies
  • Fluency in common valuation methods for mid-cap biotech including DCF, Multiples, SOTP

Preferred Experience
Modeling expertise in determining upside/downside stock price movement based on clinical trial outcomes

Location
This is a fully remote position. Candidates can be based in any time zone within six hours of US EST.  

Compensation
Commensurate with experience and ability.  Includes both base pay and stock options.

About us
Diviner is a unique startup applying human-centered prediction science to forecast drug development outcomes and their impact on stock prices. 

  • Our vision is to enable the industry to prioritize better medicines.
  • Our exclusive forecaster network – made up of biopharma professionals, licensing executives, venture capitalists, equity research professionals, biotech C-suite leaders and physicians – forecasts clinical trial outcomes. 

Diviner is committed to hiring and retaining a diverse workforce. We are proud to be an Equal Opportunity/Affirmative Action-Employer, making decisions without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability status, age, marital status, protected veteran status or any other protected class. 

Your application information will be kept confidential according to EEO guidelines.